Skip to main content

New top story from Time: Pfizer-BioNTech Have Started Testing Their COVID-19 Vaccine in Children Under 12

https://ift.tt/3vWOQjL

Alejandra and Marisol Gerardo are nine years old but already making a little bit of history. The twin sisters are among the first young children to get vaccinated with a COVID-19 shot in Pfizer-BioNTech’s study of its vaccine in kids under age 12.

Alejandra and Marisol had their blood drawn in the morning on March 24, then got their first dose of the two-dose vaccine later that afternoon. “Their primary concern was, ‘is it going to hurt,’” says their father, Dr. Charles Gerardo, chief of emergency medicine at Duke University School of Medicine. “They’re not too worried about the long term side effects; they’re looking at the moment, not the future.”

Testing the vaccine in younger children will answer critical questions about how much immunity the shots can provide, and potentially give parents and education officials more confidence in re-opening schools. While it appears that younger children don’t get as sick with COVID-19 as older teens and adults do, how these children’s immune systems respond to the virus, and to the vaccine, remains a black box. The trial will also help provide some clarity on those questions.

Pfizer-BioNTech says it will test the same vaccine that is currently authorized for emergency use in the U.S. for those 16 years and older, but this time in children aged six months to 11 years. The company is currently wrapping up a study of its two-dose shot in adolescents aged 12 to 15 years in the U.S. and Europe.

The latest pediatric trial will follow the same three-phased approach as the adult study, with Phase 1 involving 144 children aged five to 11 years at Duke, Boston Children’s Hospital, Cincinnati Children’s Hospital and Johns Hopkins, who will all receive the vaccine but be randomly assigned one of three dosages. If the vaccine is safe in this age group, children aged two to four years will be tested, and if safe in that group, the youngest children from six months to two years will get the vaccine. Depending on the immune responses these children generate, the scientists at Pfizer-BioNTech will make a decision about the safest and most effective dose with which to proceed in its Phase 2 and Phase 3 studies.

Those will include a total of about 4,500 children broken down in the same age categories, this time randomly assigned to receive either the vaccine or placebo in a 2:1 ratio. The results will be analyzed after six months to determine if the children receiving the vaccine both generated a stronger immune response than those getting placebo, and that the response was on par with responses in vaccinated adults. If that’s the case, then Pfizer-BioNTech will submit the data to the U.S. Food and Drug Administration to expand authorization to younger children, and hopefully start vaccinating them by early next year.

Dr. Emmanuel Walter, professor of pediatrics and chief medical officer at the Duke Human Vaccine Institute who is overseeing the trial there, says the study will answer important questions about the safety and dosing of the vaccine for children—specifically whether younger children will need a different dose than adolescents and adults. The trial will test a dose about one-third that of the current adult dose, another that is about half of the adult dose, as well as the adult dose. While the Pfizer-BioNTech COVID-19 shot is the first mRNA technology-based vaccine of any kind to gain FDA authorization, Walter says it’s likely to be safe in children. “I don’t think it’s the platform so much that I would worry about for young children—I feel comfortable giving the mRNA to young children. I think the questions of will they have side effects, will the vaccine be tolerable to children, and do we need to use a smaller dose in young kids, are the biggest things.”

So far, Walter says that they have seen an “overwhelming” response to the pediatric trial, with parents like the Gerardos expressing interest in enrolling their children. Both Gerardo and his wife, who is an infectious disease physician at Duke, are vaccinated, and he says before his daughters joined the trial, they discussed volunteering with the girls. “They understand that the results are going to impact other kids, and that’s one of the lessons we wanted to teach them with this experience,” he says. “That this was one of the ways to contribute to help other people.”

Comments

Popular posts from this blog

Over dozen shops gutted in fire in Greater Noida market https://ift.tt/2Di1kfv

Around a dozen shops were gutted after a fire broke out at a market in Greater Noida (West) area of Uttar Pradesh's Gautam Buddh Nagar on Thursday night, officials said. The fire is suspected to have started around 8.30 pm with a short circuit in a home appliances shop and then spread to other outlets in the market, located in Bisrakh police station area, the officials said.

Scientists uneasy as Russia approves 1st coronavirus vaccine https://ift.tt/3gOLOWL

Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease because the shots have only been studied in dozens of people.

सही पकड़े हैं - आपकी अंगूरी भाभी शुभांगी अत्रे को मिल गया है बिग बॉस 14 का न्योता

भाभी जी घर पर हैं, फैन्स के फेवरिट धारावाहिकों में से एक है और इसकी किरदार अंगूरी भाभी तो घर घर में चर्चित हैं। अब आपकी अंगूरी भाभी यानि कि शुभांगी अत्रे को बिग बॉस के घर में बंद होने का from टेलीविजन की खबरें | Television News in Hindi | TV Serials Update in Hindi – FilmiBeat Hindi http:/hindi.filmibeat.com/television/bhabhi-ji-ghar-par-hain-angoori-bhabhi-shubhangi-atre-approached-for-bigg-boss-14-090111.html?utm_source=/rss/filmibeat-hindi-television-fb.xml&utm_medium=104.71.130.47&utm_campaign=client-rss

New top story from Time: Joe Biden Is Getting His Booster Shot Today

https://ift.tt/3ALygVX WASHINGTON — President Joe Biden will receive his COVID-19 booster shot on Monday, days after federal regulators recommended a third dose of the Pfizer vaccine for Americans age 65 or older and approved them for others with preexisting medical conditions and high-risk work environments. The White House said Biden, 78, would deliver remarks and receive the additional dose at 1 p.m. Monday. Biden got his first shot on Dec. 21 and his second dose three weeks later, on Jan. 11, along with his wife, Jill Biden. It was not immediately clear whether the first lady would also receive the booster dose on Monday. Speaking on Friday after the Centers for Disease Control and Prevention and the Food and Drug Administration authorized the Pfizer booster, Biden told reporters, “I’ll be getting my booster shot. It’s hard to acknowledge I’m over 65, but I’ll be getting my booster shot. ” Vice President Kamala Harris, 56, received the Moderna vaccine, for which feder...

Fire breaks out at shopping centre at Mumbai's Borivali West; efforts to douse flames on https://ift.tt/3iORMZb

A fire was reported at Mumbai's Borivali West early on Saturday. Nearly 14 fire tenders are present at the spot as the efforts to douse the flames continue.  from IndiaTV: Google News Feed https://ift.tt/2W9DhW9

New top story from Time: Tropical Storm Zeta Expected to Hit U.S. Gulf Coast by Midweek

https://ift.tt/2J1aWNX (MIAMI) — A strengthening Tropical Storm Zeta is expected to become a hurricane Monday as it heads toward the eastern end of Mexico’s resort-dotted Yucatan Peninsula and then likely move on for a possible landfall on the central U.S. Gulf Coast at midweek. Zeta, which on Sunday became the earliest ever 27th named storm of the Atlantic season, was centered about 260 miles (420 kilometers) southeast of Cozumel island late Sunday, the U.S. National Hurricane Center said. It had maximum sustained winds of 60 mph (95 kph). Though nearly stationary, the storm was expected to begin advancing on a path that would take it over the Yucatan Peninsula late Monday. It would then head into the Gulf of Mexico and approach the U.S. Gulf Coast by Wednesday, though it could weaken by then, the hurricane center said. Officials in Quintana Roo state, the location of Cancun and other resorts, said they were watching the storm. They reported nearly 60,000 tourists in th...

New top story from Time: Report: Homicides Continue to Slowly Rise in the U.S., While Other Violent Crimes Declines

https://ift.tt/3yp5v05 A new report from the Council on Criminal Justice (CCJ) presents data showing that murders have risen 16% in many major American cities over the first 6 months of 2021, as part of what is being widely viewed as a new wave of crime and violence across the U.S. But according to the report, when compared to the same time period last year, the pace of the increase in murders has slowed down from the first quarter of 2021 through the second: In the first quarter of 2021, homicides rose by 23% compared to last year. In the second quarter, they rose by just 10%. [time-brightcove not-tgx=”true”] By the numbers , these Q1/Q2 percentile rises represent 47 murders reported in Portland, Ore. in the first half of 2021 (versus 11 in the equivalent period of 2020), Houston with 228 murders (versus 173 in 2020) and Buffalo, N.Y. with 46 (versus 31 in 2020). But cities like St. Louis saw drops from 156 murders in the first half of 2020 to 108 so far this year, and Bos...

New top story from Time: 8 People Involved in Tokyo Olympic Torch Relay Infected With COVID-19

https://ift.tt/3vATfb8 Eight people who were involved in the the torch relay for the Tokyo Olympics have tested positive for COVID-19—the latest sign of trouble for Japan as it both struggles with a spike in infections and prepares for the Games this summer. More than 70% of people in Japan want the Olympics, which begin July 23, to be canceled or postponed, according to an April poll by Kyodo News . Runners of the relay, which began its journey to Tokyo on March 25 in Fukushima , have faced heckling and protests . The Japanese government, however, insists that the Games will go ahead following their delay in 2020 due to the pandemic. COVID-19 protocols released last month rely on frequent testing and isolation bubbles for athletes and coaches, but not strict quarantines or vaccinations. Fans from abroad have been banned, and organizers are weighing whether to bar Japanese spectators, as well . On Sunday, the country reported 5,900 new infections, and the number of COVI...

FOX NEWS: Bride's father asks stepdad to help walk her down the aisle in sweet viral moment A selfless gesture by the father of a bride was shared on social media in a viral moment of him surprising the girl’s stepfather by asking him to help walk her to the altar.

Bride's father asks stepdad to help walk her down the aisle in sweet viral moment A selfless gesture by the father of a bride was shared on social media in a viral moment of him surprising the girl’s stepfather by asking him to help walk her to the altar. via FOX NEWS https://ift.tt/YysR7TE

New top story from Time: Our Eyes on the Virus: Why We Still Need Widespread Rapid Testing Even With Vaccines

https://ift.tt/3i5MoTN The vaccines are here. Why do we still need testing? Testing is our eye on the virus. Without testing, we can’t see where it is or where it is going. As fall and winter set in, outbreaks will again occur, sparked by the unvaccinated. And most people become infectious before they know they are infected. Frequent and accessible rapid testing is a tool that if deployed last summer and fall would have saved 100,000 lives. The U.S. missed the opportunity to use frequent rapid testing to stop individuals from unintentionally spreading the lethal SARS-CoV-2 virus to our most vulnerable and avert the horrific winter surge. By rapid tests, I mean the tests that an individual can conduct without a laboratory (ideally in the privacy of their own home) with results given in real-time. There are two types: rapid antigen tests, which look for the virus’s proteins and detect infectious levels of virus. The other lets you know you’ve been infected: rapid molecular...